Hongrui Meng | Neurodegenerative disease | Excellence in Research Award

Posted on by Neuroscientists

Prof. Dr. Hongrui Meng | Neurodegenerative disease | Excellence in Research Award

Prof. Dr. Hongrui Meng,  Institute of Neuroscience, Soochow University, China.

Dr. Hongrui Meng is a highly accomplished neuroscientist whose academic path began with a Ph.D. in Behavioural Neuroscience from Hamamatsu University School of Medicine in Japan. He later conducted postdoctoral research in molecular neurobiology and human genetics at Juntendo University, Tokyo. Currently a professor at the Institute of Neuroscience, Soochow University, Dr. Meng leads a research team dedicated to uncovering the molecular and mitochondrial mechanisms underlying Parkinson’s disease and ALS. His work spans high-impact research projects funded by JSPS, NSFC, and other prestigious bodies. In addition to numerous scientific publications, he has contributed to diagnostic innovation through patented miRNA detection methods. His influence extends beyond academia through translational applications such as wearable technologies for Parkinson’s symptom monitoring.

Profile

Orcid

🎓 Early Academic Pursuits

Dr. Hongrui Meng began his distinguished academic journey in the field of neuroscience by earning his Ph.D. in Behavioural Neuroscience from the prestigious Hamamatsu University School of Medicine in Japan. His early education and training laid a strong foundation in experimental neuroscience, with a focus on the behavioral manifestations of neurodegenerative conditions. These formative years not only sharpened his scientific curiosity but also equipped him with the cross-disciplinary expertise to address complex neurological questions.

🧠 Professional Endeavors

Following his doctoral studies, Dr. Meng advanced his specialization through postdoctoral training in molecular neurobiology and human genetics at Juntendo University in Tokyo. There, he immersed himself in high-level research focusing on the genetic underpinnings of neurological disorders. His competence and dedication soon earned him a faculty appointment as an Assistant Professor in the Department of Research for Neurodegenerative Diseases and Dementia. His professional arc reached a significant milestone in 2020 when he was promoted to Full Professor and moved to the Institute of Neuroscience at Soochow University, where he now leads the Laboratory of Molecular Neurology.

🧬 Contributions and Research Focus

Dr. Meng’s scientific contributions center on the molecular mechanisms of Parkinson’s disease and amyotrophic lateral sclerosis (ALS). His research bridges mitochondrial dysfunction, alpha-synuclein aggregation, and neurodegeneration. He has completed pivotal studies supported by the Japan Society for the Promotion of Science and the Takeda Pharmaceutical Foundation, delving into the role of CHCHD2 gene mutations and mitochondrial pathways. His ongoing projects funded by the National Natural Science Foundation of China (NSFC) explore mitochondrial unfolded protein responses (mtUPR), while another innovative project in Suzhou focuses on wearable technology for monitoring Parkinson’s disease symptoms—demonstrating his commitment to translational and patient-centered neuroscience.

🔬 Innovation and Scientific Output

A notable innovator, Dr. Meng has made strides in molecular diagnostic technologies. His work has led to the development of high-throughput RT-qPCR-based methods for detecting primary and precursor miRNAs, contributing to enhanced genetic analysis of neurodegenerative disorders. He holds a patent granted in South Africa and another under process in China, underscoring his role at the intersection of research and technology. Furthermore, his publications in highly regarded journals like Current Issues in Molecular Biology and Cell Communication and Signaling reflect a consistent record of impactful findings that inform both fundamental neuroscience and clinical approaches.

🏅 Accolades and Recognition

Dr. Meng’s ascent in the academic community has been marked by numerous grants, including multiple from the JSPS and NSFC, attesting to the trust placed in his research vision by top funding bodies. While a formal list of awards may be under-documented, his rapid progression from postdoctoral fellow to professor and research team leader in less than a decade speaks volumes about his recognition among peers and institutional leadership. His leadership in multi-disciplinary and international collaborations is an implicit accolade of his scientific reliability and visionary perspective.

🌍 Impact and Influence

Through his groundbreaking work on mitochondrial mechanisms and neurodegeneration, Dr. Meng is helping to reshape current understanding of Parkinson’s disease pathophysiology. His investigations into alpha-synucleinopathy and microglial disruption have provided fresh insights into cellular degeneration and neuroimmune interactions. Beyond academia, his involvement in developing wearable diagnostic tools highlights his drive to impact patient lives directly. As a consultant on neuroprotective treatments such as PD-018/19, he bridges the academic and pharmaceutical worlds to accelerate therapeutic discovery.

🔮 Legacy and Future Contributions

Looking forward, Dr. Meng is poised to be a leading figure in neurogenetic diagnostics and therapeutic innovation. His laboratory at Soochow University serves as an incubator for future discoveries in neurodegenerative disease mechanisms, and his continued work in mitochondrial research promises to inform emerging therapies. With a growing publication record, international patents, and a robust research pipeline, Dr. Meng’s legacy will be one of bridging basic neuroscience with clinical application—paving the way for novel interventions and a better understanding of brain disorders in the molecular era.

Publication

 

  • Title: Dicer Is Involved in Cytotoxicity and Motor Impairment Induced by TBPH Deficiency
    Authors: Xiang Long, Yijie Wang, Hongrui Meng
    Year: 2025

 

  • Title: Transcriptomic analysis of lipid metabolism genes in Alzheimer’s disease: highlighting pathological outcomes and compartmentalized immune status
    Authors: Sun Y., Zhang Y., Jiang M., Long X., Miao Y., Du H., Zhang T., Meng H., Ma X.
    Year: 2024

 

  • Title: CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasis
    Authors: Aya Ikeda, Hongrui Meng, Daisuke Taniguchi, Muneyo Mio, Manabu Funayama, Kenya Nishioka, Mari Yoshida, Yuanzhe Li, Hiroyo Yoshino, Tsuyoshi Inoshita et al.
    Year: 2024

 

  • Title: TDP-43 mutations-induced defects in miRNA biogenesis and cytotoxicity by differentially obstructing Dicer activity in Drosophila and in vitro
    Authors: Xiang Long, Mengni Jiang, Yongzhen Miao, Huanhuan Du, Ting Zhang, Zhuoya Ma, Jiao Li, Chunfeng Liu, Hongrui Meng
    Year: 2024

 

  • Title: A Simple Technique to Assay Locomotor Activity in Drosophila
    Authors: Long X., Du H., Jiang M., Meng H.
    Year: 2023

 

  • Title: Functional MHCI deficiency induces ADHD-like symptoms with increased dopamine D1 receptor expression
    Authors: Meng H.-R., Suenaga T., Edamura M., Nakahara D., Murakami G., Fukuda A., Ishida Y.
    Year: 2021

 

  • Title: Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson’s disease
    Authors: Imai Y., Hattori N., Inoshita T., Shiba-Fukushima K., Meng H., Hara K.Y., Sawamura N.
    Year: 2019

 

  • Title: Mutations in CHCHD2 cause α-synuclein aggregation
    Authors: Ikeda A., Nishioka K., Takanashi M., Li Y., Mori A., Okuzumi A., Izawa N., Ishikawa K.-I., Funayama M., Imai Y. et al.
    Year: 2019

 

  • Title: Parkinson’s disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling
    Authors: Mori A., Hatano T., Koinuma T., Kubo S.-I., Spratt S., Yamashita C., Okuzumi A., Imai Y., Hattori N., Inoshita T. et al.
    Year: 2019

 

  • Title: Twin CHCH proteins, CHCHD2, and CHCHD10: Key molecules of Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia
    Authors: Imai Y., Hattori N., Meng H., Shiba-Fukushima K.
    Year: 2019

 

🧾 Conclusion

Dr. Hongrui Meng’s career reflects a dynamic blend of academic excellence, molecular research innovation, and translational neuroscience. His scientific endeavors have not only enriched the understanding of neurodegenerative diseases but have also paved the way for novel diagnostic and therapeutic strategies. With a growing portfolio of impactful research, patents, and leadership in neurobiology, Dr. Meng stands out as a driving force in the global fight against neurological disorders. His work promises continued contributions to neuroscience with lasting influence on both scientific knowledge and patient care.

 

Izabela Małysz-Cymborska | Neurogenetics | Best Researcher Award

Posted on by Neuroscientists

Assoc. Prof. Dr. Izabela Małysz-Cymborska | Neurogenetics | Best Researcher Award

Assoc. Prof. Dr. Izabela Małysz-Cymborska,  Department of Neurology and Neurosurgery, School of Medicine, University of Warmia and Mazury, Poland.

Dr. Izabela Małysz-Cymborska is a distinguished biomedical researcher and Associate Professor in Neurosurgery at the University of Warmia and Mazury, Poland. Her academic path began with a Master’s in Biology and culminated in a Ph.D. focused on hormonal mechanisms, followed by a Habilitation in Medicine. Her research spans neuroregeneration, stem cell therapy, and immunomodulatory strategies for neurological diseases such as ALS and stroke. She has led and contributed to nationally funded projects like NanoTech4ALS, Explore Me, and her current OPUS-funded investigation using a swine model for stroke therapy. Her interdisciplinary approach bridges molecular biology, reproductive science, and clinical neuroscience, demonstrating a rare ability to translate foundational research into therapeutic innovation.

Profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Izabela Małysz-Cymborska embarked on her academic journey with a deep-rooted interest in biological sciences. Born on September 21, 1985, in Poland, she pursued her undergraduate studies at the University of Warmia and Mazury in Olsztyn, earning a Master of Science degree in Biology in 2009. Her passion for advanced biomedical research led her to the Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences, where she completed her Ph.D. in 2015. Her doctoral research, grounded in hormonal action mechanisms, laid the foundation for her future contributions to neurobiology and regenerative medicine.

🧠 Professional Endeavors in Neuroscience

Dr. Małysz-Cymborska’s postdoctoral and professional journey has been largely rooted in neuroscientific investigation, with a special focus on neuroregeneration and stroke therapy. Since 2021, she has held the position of Associate Professor in the Department of Neurosurgery at the University of Warmia and Mazury. Her early postdoctoral fellowships (2015–2018) focused on pioneering work in the application of glial progenitors and stem cells in neurological disorders like ALS. These formative experiences not only enriched her research trajectory but also provided a vital bridge between animal studies and translational medicine.

🧪 Research Focus and Scientific Contributions

Dr. Małysz-Cymborska’s research portfolio reflects a consistent dedication to understanding complex neural pathologies and their treatment through regenerative approaches. She has led and contributed to several national and international projects, including NanoTech4ALS, which investigated MRI-monitored transplantation techniques using hydrogel carriers for ALS treatment. Her current role as Principal Investigator in the OPUS-funded project explores an endovascular model of stroke in swine, opening new therapeutic pathways for immunomodulation. She has also delved into reproductive biology, investigating the influence of gonadotropins on prostaglandin synthesis and the function of the corpus luteum, showcasing her multidisciplinary expertise.

🧬 Bridging Regeneration and Technology

A major hallmark of Dr. Małysz-Cymborska’s work is the integration of regenerative medicine and cutting-edge biomedical technologies. Her involvement in Explore Me and NanoTech4ALS demonstrated her commitment to merging cellular therapy with advanced biomaterials and imaging. These projects explored the therapeutic potential of mesenchymal stem cells and human glial progenitors for neurodegenerative conditions, reflecting her drive to push boundaries in translational medicine and neurosurgery.

🏅 Accolades and Recognition

Dr. Małysz-Cymborska’s scientific accomplishments were recognized through her Habilitation Degree in Medicine, awarded in 2022 by the University of Warmia and Mazury—a prestigious academic achievement in Poland that underscores her contributions to the medical sciences. Additionally, her appointment as the Dean’s representative for animal experiments between 2018 and 2019 further illustrates the trust and respect she commands within her institution and the research community.

🌍 Impact and Influence in Translational Neuroscience

Her work has had significant implications not only in Poland but also across the global neuroscience landscape. By focusing on models that simulate real-world human neurological disorders, such as swine models for stroke and ALS, she has established platforms that can more accurately predict treatment outcomes in humans. Her collaborative efforts within national strategic medical programs have enriched the broader field of translational neuroscience, particularly in immune response modulation and neural repair mechanisms.

🔮 Legacy and Future Contributions

As her OPUS project continues until 2025, Dr. Izabela Małysz-Cymborska is poised to deliver crucial insights into stroke immunotherapy. Her legacy lies in her ability to traverse boundaries between endocrinology, neurobiology, and regenerative therapy—crafting a unique niche that advances both fundamental science and clinical application. With a promising trajectory ahead, she is set to influence future protocols in neurovascular therapy, offering hope to patients with currently untreatable conditions.

Publication

  • Hydrogel-based scaffolds to support intrathecal stem cell transplantation as a gateway to the spinal cord: clinical needs, biomaterials, and imaging technologies
    Authors: JM Oliveira, L Carvalho, J Silva-Correia, S Vieira, M Majchrzak, …
    Year: 2018

 

  • Advances in bioinks and in vivo imaging of biomaterials for CNS applications
    Authors: EP Oliveira, I Malysz-Cymborska, D Golubczyk, L Kalkowski, …
    Year: 2019

 

  • The role of glia in canine degenerative myelopathy: relevance to human amyotrophic lateral sclerosis
    Authors: D Golubczyk, I Malysz-Cymborska, L Kalkowski, M Janowski, JR Coates, …
    Year: 2019

 

  • Methacrylated gellan gum and hyaluronic acid hydrogel blends for image-guided neurointerventions
    Authors: S Vieira, P Strymecka, L Stanaszek, J Silva-Correia, K Drela, …
    Year: 2020

 

  • MRI-guided intrathecal transplantation of hydrogel-embedded glial progenitors in large animals
    Authors: I Malysz-Cymborska, D Golubczyk, L Kalkowski, A Burczyk, M Janowski, …
    Year: 2018

 

  • Endovascular model of ischemic stroke in swine guided by real-time MRI
    Authors: D Golubczyk, L Kalkowski, J Kwiatkowska, M Zawadzki, P Holak, J Glodek, …
    Year: 2020

 

  • Expression of the vascular endothelial growth factor receptor system in porcine oviducts after induction of ovulation and superovulation
    Authors: I Małysz-Cymborska, A Andronowska
    Year: 2014

 

  • Rabbit model of human gliomas: implications for intra-arterial drug delivery
    Authors: H Qin, M Janowski, MS Pearl, I Malysz-Cymborska, S Li, CG Eberhart, …
    Year: 2017

 

  • Two in one: use of divalent manganese ions as both cross-linking and MRI contrast agent for intrathecal injection of hydrogel-embedded stem cells
    Authors: L Kalkowski, D Golubczyk, J Kwiatkowska, P Holak, K Milewska, …
    Year: 2021

 

  • Effect of hCG and eCG treatments on Prostaglandins Synthesis in the Porcine Oviduct
    Authors: I Małysz‐Cymborska, AJ Ziecik, A Waclawik, A Andronowska
    Year: 2013

 

🧾 Conclusion

Dr. Małysz-Cymborska’s career reflects a compelling fusion of scientific curiosity, clinical relevance, and academic rigor. With notable achievements in regenerative medicine and translational neuroscience, she continues to shape the future of therapeutic interventions for complex neurological disorders. Her ongoing research promises to pave the way for advanced stroke treatments and immune-based neurotherapies, cementing her role as a key contributor to modern biomedical science.

Joice Margareth de Almeida Rodolpho | Molecular Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Mrs. Joice Margareth de Almeida Rodolpho | Molecular Neuroscience | Best Researcher Award

Mrs. Joice Margareth de Almeida Rodolpho, Universidade Federal de São Carlos, Brazil.

Joice Margareth de Almeida Rodolpho is a dedicated Brazilian researcher with a strong foundation in biotechnology, parasitology, immunology, and molecular biology. She earned her Master’s and Ph.D. from the Federal University of São Carlos (UFSCar), where she explored the role of eosinophils as antigen-presenting cells in parasitic infections like Toxocara canis and Schistosoma mansoni. Her work is recognized for integrating experimental immunology with therapeutic innovations, such as the evaluation of natural plant extracts and nanomaterials for infection control. She further specialized in Flow Cytometry and Oncohematology, enhancing her analytical capabilities. With multiple awards and citations, her impactful contributions continue to strengthen Brazil’s standing in parasitological and immunological research.

Profile

Orcid

🎓 Early Academic Pursuits

Joice Margareth de Almeida Rodolpho began her academic journey in Brazil, developing a strong foundation in the life sciences. Her early interest in molecular biology and parasitology led her to pursue advanced studies at the esteemed Universidade Federal de São Carlos (UFSCar). She earned her Master’s degree in Biotechnology between 2009 and 2012, conducting significant research on Toxocara canis, particularly on the phenotypic characterization of eosinophils as antigen-presenting cells. This early work not only revealed her meticulous scientific inquiry but also laid the groundwork for her deeper exploration into immunology.

🧬 Professional Endeavors in Molecular and Evolutionary Genetics

Driven by a passion for understanding immune responses, Joice pursued a Ph.D. in Evolutionary Genetics and Molecular Biology at UFSCar from 2013 to 2017. Her doctoral research focused on the role of eosinophils as antigen-presenting cells both in vitro and ex vivo, offering vital insights into host-parasite interactions and immune regulation. Her work during this period was supported by a prestigious FAPESP scholarship, demonstrating her academic excellence and the relevance of her contributions. Under the mentorship of Professor Fernanda de Freitas Anibal, Joice refined her skills in experimental immunology and cellular biology.

🧪 Contributions and Research Focus in Parasitology and Immunopathology

Joice Rodolpho’s primary research interests lie at the intersection of parasitology, cellular immunology, and experimental pathology. Her studies explore how parasitic infections, such as those caused by Schistosoma mansoni and Toxocara canis, affect immune cell function, especially eosinophils. She has also contributed to investigations into natural plant extracts, like Mentha piperita L., assessing their therapeutic potential in modulating parasitic infections. Moreover, she extended her expertise to the field of nanomaterials, evaluating the cytotoxicity and cell death mechanisms induced by compounds like Ag₂WO₄, thus bridging classical parasitology with emerging biomedical technologies.

🏅 Accolades and Recognition in Scientific Circles

Throughout her career, Joice has received several recognitions that reflect the impact and originality of her research. In 2010, she was honored with a Menção Honrosa (Honorable Mention) for her work on Mentha piperita L. in treating Schistosoma mansoni, earning 2nd place in diagnostics and treatment. She continued to gain academic acclaim with awards at major conferences, including the VI Congresso da Sociedade Paulista de Parasitologia (2012) and the XXII B-MRS Meeting in 2024, highlighting her work on cytotoxic responses and innovative parasitological control methods. In 2024, her project on the parasitological and pathological evaluation of AW-HRL-C for schistosomiasis control was notably recognized by UNIFESP.

🧠 Impact and Influence in Experimental Immunology

Joice’s dedication to experimental immunology and cytometry has allowed her to mentor and influence upcoming researchers, especially in specialized fields such as flow cytometry. Her recent specialization in Immunology and Oncohematology by Flow Cytometry (2021–2022) at IPESSP further enriched her profile, showcasing her commitment to continuous learning and application of advanced technologies in immune profiling. Her ability to merge classical immunopathology with state-of-the-art cytometric tools reflects her versatility and forward-thinking scientific approach.

🌱 Legacy and Future Contributions in Biomedical Science

Poised to make lasting contributions, Joice Margareth de Almeida Rodolpho stands at the forefront of research into host-pathogen interactions, parasitic disease management, and immune cell function modulation. Her unique interdisciplinary approach—integrating molecular biology, natural product pharmacology, and immunological techniques—positions her as a valuable contributor to both academic research and potential therapeutic advancements. She is expected to lead innovative research in the treatment of neglected tropical diseases and immunological disorders, with implications for global health.

🔬 Research Field Relevance and Scientific Identity

As a scholar deeply embedded in the Brazilian scientific ecosystem, Joice’s identity is reflected in her multiple citation forms, indicating her widespread academic collaborations and international visibility. Her expertise bridges evolutionary genetics, biotechnology, cytometry, and immunoparasitology—making her a multifaceted researcher. Her contributions are cited under various names such as “RODOLPHO, JOICE M. A.” and “Joice Margareth de Almeida Rodolpho,” reflecting a robust presence in scholarly literature and ensuring her work continues to guide parasitological and immunological research for years to come.

Publication

  • Title: Biomarkers and Mental Disorders: A Relevance Analysis Using a Random Forest Algorithm
    Authors: Joice M. A. Rodolpho; Krissia F. Godoy; Bruna D. L. Fragelli; Jaqueline Bianchi; et al.
    Year: 2025

 

  • Title: Death Risk Score Model of Hospitalized COVID‐19 Patients: A Cohort Study
    Authors: Gustavo A. Cruz; Thais B. Boteon; Henrique Pott; Joice M. A. Rodolpho; et al.
    Year: 2025

 

  • Title: Synergistic Antifungal Effect and In Vivo Toxicity of a Monoterpene Isoespintanol Obtained from Oxandra xylopioides Diels
    Authors: Orfa I. C. Martínez; Alberto Angulo; Joice Rodolpho; Krissia F. Godoy; et al.
    Year: 2024

 

  • Title: Synergistic Antifungal Effect and In Vivo Toxicity of the Monoterpene Isoespintanol Obtained from Oxandra xylopioides Diels (Preprint)
    Authors: Orfa I. C. Martínez; Alberto Angulo; Joice M. A. Rodolpho; et al.
    Year: 2024

 

  • Title: Carbon Black CB-EDA Nanoparticles in Macrophages: Changes in the Oxidative Stress Pathway and in Apoptosis Signaling
    Authors: Joice M. A. Rodolpho; Krissia F. Godoy; Bruna D. L. Fragelli; et al.
    Year: 2023

 

  • Title: HGPRT and PNP: Recombinant Enzymes from Schistosoma mansoni and Their Role in Immunotherapy during Experimental Murine Schistosomiasis
    Authors: Bruna D. L. Fragelli; Ana C. Fattori; Joice M. A. Rodolpho; et al.
    Year: 2023

 

  • Title: Titanium Dioxide Nanoparticle (TiO2 NP) Induces Toxic Effects on LA-9 Mouse Fibroblast Cell Line
    Authors: Ana C. M. Fattori; Patricia Brassolatti; Joice M. A. Rodolpho; et al.
    Year: 2023

 

  • Title: Analysis of Cytotoxicity and Genotoxicity in a Short-Term Dependent Manner Induced by a New Titanium Dioxide Nanoparticle in Murine Fibroblast Cells
    Authors: Pedrino, M.; Brassolatti, P.; Joice M. A. Rodolpho; et al.
    Year: 2022

 

  • Title: Functionalized Titanium Nanoparticles Induce Oxidative Stress and Cell Death in Human Skin Cells
    Authors: Brassolatti, P.; Joice M. A. Rodolpho; Krissia F. Godoy; et al.
    Year: 2022

 

  • Title: Toxicological Effects of the Mixed Iron Oxide Nanoparticle (Fe₃O₄ NP) on Murine Fibroblasts LA-9
    Authors: Alves Feitosa, K.; Joice M. A. Rodolpho; et al.
    Year: 2022

 

🧾 Conclusion

Joice Rodolpho’s academic journey and scientific contributions reveal a researcher of high caliber, committed to advancing our understanding of host-pathogen dynamics and immune system function. Her work, grounded in rigorous experimentation and innovation, holds promise for developing novel therapies for neglected tropical diseases. With a forward-looking approach and interdisciplinary expertise, she stands out as a key contributor in biomedical science, poised to influence future discoveries in immunopathology and disease control.

Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Dr.  Liliana Elena Weimer, Center For Global Health Istituto Superiore di Sanita’ Rome, Italy.

Dr. Liliana Elena Weimer is a highly accomplished physician and clinical researcher , where she has risen to the prestigious Level II “First Researcher” position. Her professional focus lies in clinical trials for infectious diseases, particularly HIV and Hepatitis C. She has played a critical role in major national and international research efforts, including collaborations with the U.S. Clinical Trials Group and leadership of the large-scale PITER cohort involving 25,000 HCV patients. She is known not only for her scientific contributions but also for her humanitarian efforts during the COVID-19 emergency. Among her recognitions is the 1st Prize at the 2019 International Congress on Hepatitis C in Seville. Throughout her career, she has exemplified scientific integrity, dedication, and service to public health.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born on December 19, 1965, in Buenos Aires to Italian parents, Dr. Liliana Elena Weimer embraced her dual heritage and committed herself to a life in medicine and research. With Italian citizenship and deep academic determination, she laid the groundwork for her career by studying medicine, ultimately finding her professional home in Italy. Her academic path, though not fully detailed, clearly led her toward a focus on clinical medicine and infectious diseases, with her earliest professional roles marking the beginning of a lifelong engagement in public health and biomedical research. Her intellectual dedication and international roots later became an asset in global research collaborations.

🩺 Professional Endeavors

Dr. Weimer’s distinguished career spans over three decades at the Italian National Institute of Health (ISS), beginning in 1985. Starting as a dedicated clinical physician, she ascended to Level III researcher status by 1990 and continued to grow into higher ranks, culminating in her success in the national Art. 15 competition for the Level II “First Researcher” role in 2022, officially backdated to 2021. Throughout her tenure at ISS, she became a central figure within the Global Health Center in Rome. Known for her tireless commitment, she often described her career not simply as a job but as a “mission,” emphasizing both her personal and professional passion for making a difference in human health.

🧪 Contributions and Research Focus

Specializing in clinical trials, Dr. Weimer has coordinated and participated in numerous groundbreaking studies in HIV and Hepatitis C (HCV). Since the early 1990s, she has collaborated closely with renowned figures such as Prof. Giovanni Rossi, Prof. Stefano Vella, and Prof. Gianni Rezza, contributing to some of the most pivotal HIV antiretroviral therapy trials in history. Her research efforts extended to co-leading and organizing both national and international multicenter clinical trials. Notably, she has been at the forefront of the PITER study, a major nationwide cohort that follows 25,000 patients undergoing HCV treatment—one of the most comprehensive initiatives in Italy in the fight against hepatitis.

🌍 Global Collaborations and Humanitarian Engagement

Her impact extends beyond Italy, thanks to her active involvement with the U.S.-based American Clinical Trials Group on HIV studies. These collaborations have enhanced international understanding and treatment of HIV/AIDS. In addition to her clinical and research commitments, Dr. Weimer also devoted herself to frontline service during the COVID-19 pandemic. Volunteering both with the Civil Protection unit and at Bambino Gesù Children’s Hospital, she demonstrated profound humanitarian values. Her presence during a critical time underscored her belief in serving communities not just from behind a lab desk but also on the ground, directly supporting patients and health systems under strain.

🏅 Accolades and Recognition

Dr. Weimer’s work has been acknowledged at both national and international levels. One of the most prominent recognitions she received was the 1st Prize at the International Congress on Hepatitis C held in Seville in November 2019, a testament to her excellence and influence in the field of infectious disease research. Her achievements are not only measured in accolades but also in the tangible difference her work has made in advancing therapy options and clinical management of chronic viral diseases. Her rise within the ISS and the trust placed in her leadership of major research projects further affirm her standing within the scientific community.

💡 Impact and Influence

Over the course of her extensive career, Dr. Weimer has significantly shaped clinical research strategies in Italy, especially regarding chronic viral infections. Her coordination of thousands of patient cases within structured clinical trials has informed policy decisions and improved treatment protocols nationwide. Her presence at the ISS has also influenced future generations of researchers and clinicians, many of whom benefited from her mentorship, leadership, and example of scientific integrity. Through her rigorous methods and patient-focused approach, she has played a key role in Italy’s standing as a leader in global health research, especially in relation to HIV and HCV.

🔬 Legacy and Future Contributions

Looking forward, Dr. Weimer’s contributions will continue to echo through the fields of virology and clinical medicine. Her involvement in the PITER cohort and other studies has laid down essential groundwork for long-term epidemiological surveillance and patient care strategies. With her appointment as First Researcher, she enters a new chapter of leadership, likely to drive more innovative, patient-centered research initiatives in global health. Her legacy lies not only in her publications or awards but also in the thousands of lives improved by the treatments she helped to test, refine, and implement. The combination of scientific rigor and heartfelt service defines her enduring contribution to modern medicine.

Publication

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C – TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, … – 2010

 

  • Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‐year follow‐up of 150 patients – SL George, BR Bacon, EM Brunt, KL Mihindukulasuriya, J Hoffmann, … – 2009

 

  • Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis – V Saxena, L Nyberg, M Pauly, A Dasgupta, A Nyberg, B Piasecki, … – 2015

 

  • Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy – D Persaud, SC Ray, J Kajdas, A Ahonkhai, GK Siberry, K Ferguson, … – 2007

 

  • Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real‐world cohort study – EB Tapper, BR Bacon, MP Curry, DT Dieterich, SL Flamm, LE Guest, … – 2016

 

  • Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA – S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, … – 2009

 

  • Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study – R Mellado-Artigas, LE Mujica, ML Ruiz, BL Ferreyro, F Angriman, E Arruti, … – 2021

 

  • A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients – M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, … – 1999

 

  • Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort – LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, … – 2017

 

  • Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER network – LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, … – 2017

 

🏁 Conclusion

Dr. Weimer stands as a distinguished figure in the field of global health research, with deep expertise in clinical trials and infectious diseases. Her legacy is marked by landmark contributions to HIV and HCV treatment protocols, influential collaborations, and compassionate public service. Her ongoing work continues to shape public health policy and medical research in Italy and beyond. As she advances in her leadership role at the ISS, her experience, insight, and dedication will remain vital to future innovations in clinical research and global health.

Ayman M. Ibrahim | Neurochemistry | Best Academic Researcher Award

Posted on by Neuroscientists

Mr. Ayman M. Ibrahim | Neurochemistry | Best Academic Researcher Award

Mr. Ayman M. Ibrahim,  Department of Mining Engineering, University of Nyala, Sudan.

Ayman Mohamed Hassan Ibrahim is a dedicated researcher and academic in the field of mineral processing and mining engineering, with over nine years of experience in Chinese and Sudanese academic institutions. Holding a Ph.D. in Mineral Processing Engineering, he is currently serving as an Assistant Professor at the University of Nyala and a Postdoctoral Researcher at Kunming University of Science and Technology. His academic journey reflects a deep commitment to innovation, sustainability, and the advancement of mineral extraction technologies. Ayman has made notable contributions to the scientific understanding of malachite flotation, publishing extensively in SCI-indexed journals and engaging in international collaborations. Fluent in Arabic, English, and Chinese, he bridges cultural and scientific boundaries, mentoring students and influencing sustainable mining practices across borders.

Profile

Google Scholar
Orcid
Scopus

🎓 Early Academic Pursuits

Ayman Mohamed Hassan Ibrahim’s journey into the world of mineral engineering began with a strong academic foundation. He earned his Bachelor of Science in Mining Engineering from Omdurman Islamic University in 2012, which laid the groundwork for his passion in geosciences and mineral technology. His academic drive led him to pursue a Master of Science in Mining Technology at the Sudan Academy of Sciences, graduating in 2017. He then earned his Ph.D. in Mineral Processing Engineering in June 2023, where he delved deeply into sustainable solutions for the mining industry. His early academic experiences were characterized by curiosity, discipline, and an eagerness to contribute to real-world challenges in mineral extraction and processing.

👨‍🏫 Professional Endeavors

Professionally, Ayman’s career has grown through diverse academic and research roles. He began his teaching journey as a Teaching Assistant at Nyala University from 2013 to 2015. Demonstrating both leadership and technical expertise, he was promoted to Lecturer at the University of Nyala between 2017 and 2018. In June 2023, he returned to the university as an Assistant Professor, where he currently teaches mineral engineering and engineering geology. He also contributes part-time as an instructor at the University of Khartoum, mentoring postgraduate students. Concurrently, Ayman holds a prestigious Postdoctoral Researcher position at Kunming University of Science and Technology, China, where he collaborates on cutting-edge projects addressing global mineral processing and sustainability challenges.

🔬 Contributions and Research Focus

Ayman’s research focus lies at the intersection of mineral processing, flotation chemistry, and environmentally sustainable mining practices. His work emphasizes enhancing flotation recovery and developing eco-friendly reagents and technologies. He is especially recognized for his contributions to the sulfurization flotation of malachite. His recent publications explore the role of novel reagents like thiourea and ammonium sulfide, investigating their performance in enhancing copper recovery. Through advanced analytical techniques like XPS, FTIR, and ToF-SIMS, Ayman’s research not only increases flotation efficiency but also deepens the mechanistic understanding of mineral surface interactions.

🏅 Accolades and Recognition

Throughout his academic and professional career, Ayman has built a reputation as a dynamic and impactful researcher. His work is published in several high-impact SCI-indexed journals, including Colloids and Surfaces A and Physicochemical Problems of Mineral Processing. These achievements reflect both the novelty and practical value of his contributions. His ability to conduct independent research, collaborate internationally, and publish in leading journals demonstrates his standing within the global mineral engineering community. His scientific insights are also widely recognized in academic conferences and professional forums, further enhancing his credibility and scholarly presence.

🌍 Impact and Influence

Ayman’s influence goes beyond academia. As a bridge between research and industry, he actively fosters academia-industry collaborations, targeting practical challenges in mineral recovery and resource efficiency. His work contributes directly to developing sustainable practices within mining enterprises, particularly in China and Sudan. By mentoring students, supervising postgraduate research, and participating in capacity-building initiatives, he plays a vital role in empowering the next generation of mining and geology professionals. His ability to fluently communicate in Arabic, English, and Chinese enhances his global connectivity and multidisciplinary impact.

🚀 Legacy and Future Contributions

Looking ahead, Ayman is poised to become a thought leader in sustainable mineral processing. His ongoing postdoctoral research in China signifies his dedication to international collaboration and scientific advancement. His vision includes innovating green technologies for mineral extraction, improving resource utilization, and integrating advanced surface chemistry with engineering practices. As a committed educator and researcher, Ayman aims to influence policy, research, and practice in sustainable mining, leaving behind a legacy of knowledge, innovation, and community advancement.

🧪 Passion for Scientific Innovation

At the core of Ayman Mohamed Hassan Ibrahim’s journey is a passion for discovery and innovation in mineral engineering. Whether through his analytical skills using tools like ARC GIS, Origin, and XPS, or his strategic approach to project management and academic writing, Ayman exemplifies the qualities of a forward-thinking researcher. His focus on improving flotation technologies and reducing environmental footprints reflects a deep commitment to both science and sustainability. As he continues to explore new frontiers in mineral processing, Ayman stands as a model of how science can be harnessed for the betterment of both industry and society.

Publication

  • Title: Improved activation of malachite sulfurization flotation by thiourea’s (CS(NH2)2): Performance and mechanism study
    Authors: Ayman M. Ibrahim; Han Wang; Jaber A. Yousif; Mohammed Elhadi; Peilun Shen; Dianwen Liu
    Year: 2024

 

  • Title: A Case Report on Cyanidation of Gold Heap Tailings at Agbash Mine in South Darfur State (Sudan)
    Author: Ayman M H Ibrahim
    Year: 2023

 

  • Title: Effect of lead ions on accidental adsorption of Calcium Lignosulphonate on chalcopyrite surface
    Authors: Su, Chao; Pei, Bin; Ibrahim, Ayman M.; Jia, Xiaodong; Cai, Jinpeng; Shen, Peilun; Liu, Dianwen
    Year: 2023

 

  • Title: Effect of pre-oxidation on copper-lead bulk concentrate flotation separation with sodium polyacrylate as galena depressant
    Authors: Cai, Jinpeng; Jia, Xiaodong; Ma, Yinyu; Ibrahim, Ayman M.; Su, Chao; Yu, Xingcai; Shen, Peilun; Liu, Dianwen
    Year: 2023

 

  • Title: Role of ammonium phosphate in improving the physical characteristics of malachite sulfidation flotation
    Authors: Ibrahim, Ayman M.; Jia, Xiaodong; Cai, Jinpeng; Su, Chao; Yu, Xingcai; Zheng, Qifang; Peng, Rong; Shen, Peilun; Liu, Dianwen
    Year: 2023

 

  • Title: Effect of Ammonium Sulfide on Sulfidization Flotation of Malachite
    Authors: Ibrahim, Ayman M.; Jia, Xiaodong; Su, Chao; Cai, Jinpeng; Shen, Peilun; Liu, Dianwen
    Year: 2022

 

  • Title: Separation of copper-sulfur using sodium polyacrylate as pyrite depressant in acidic pulp: Floatability and adsorption studies
    Author: Ayman Mohamed Hassan Ibrahim
    Year: 2022

 

🧾 Conclusion

Dr. Ayman Ibrahim’s career is a testament to the power of persistence, scientific rigor, and global collaboration. His research not only enhances mineral recovery technologies but also contributes meaningfully to environmental sustainability in the mining sector. As he continues his work in academia and postdoctoral research, Ayman is set to play a pivotal role in shaping the future of mineral processing through innovative solutions and impactful education. His legacy is being built not only through publications and projects but also through the minds he inspires and the communities he serves.

Katherine Mandeville | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Katherine Mandeville | Clinical Neuroscience | Best Researcher Award

Dr. Katherine Mandeville, University of California San Diego, United States.

Dr. Katherine Mandeville is a distinguished pediatric emergency physician and academician whose career reflects a commitment to excellence in both clinical care and research. With a strong academic foundation in biochemistry and medicine from the University of New Mexico, she pursued advanced clinical training at leading institutions such as the University of Colorado and Phoenix Children’s Hospital. Her academic and clinical trajectory has led her to a prominent role at the University of California, San Diego (UCSD), where she serves as an Associate Clinical Professor in the Department of Pediatrics, Division of Emergency Medicine at Rady Children’s Hospital.

Profile

Scopus
Orcid

 

🎓 Early Academic Pursuits

Dr. Katherine Mandeville’s journey into the medical field was rooted in a solid foundation in science and critical inquiry. She began her academic path studying biochemistry and chemical engineering at the University of New Mexico, where she also explored non-degree coursework at Albuquerque Technical Vocational Institute. Her early academic versatility revealed a strong analytical mindset and a deep interest in human health and systems. In 1999, she earned her Medical Degree from the University of New Mexico School of Medicine, setting the stage for a career centered on both patient care and research-driven excellence.

🩺 Professional Endeavors

Following her graduation from medical school, Dr. Mandeville pursued intensive clinical training at the University of Colorado Health Sciences Center, where she completed her pediatric internship, residency, and advanced to a fellowship in Pediatric Emergency Medicine at Phoenix Children’s Hospital. These formative experiences immersed her in the fast-paced, high-stakes environment of emergency pediatrics. Since joining the University of California, San Diego (UCSD), she has progressed from Associate to Assistant and now Associate Clinical Professor within the Department of Pediatrics, Division of Emergency Medicine at Rady Children’s Hospital. Her clinical role complements her academic responsibilities, fostering a dual commitment to exceptional care and education.

🔬 Contributions and Research Focus

Dr. Mandeville’s research trajectory is marked by a keen interest in bridging clinical care and evidence-based medicine. Her decision to pursue a Master of Science in Clinical Research at the University of New Mexico’s Health Sciences Center demonstrates a deliberate move toward translational science and healthcare innovation. Her work integrates real-world clinical challenges in pediatric emergency departments with scientific inquiry, focusing on improving outcomes for vulnerable pediatric populations. While her biography does not specify individual research projects or publications, her advanced training and consistent academic appointments suggest active involvement in research development, collaborative studies, or clinical protocols aimed at advancing pediatric emergency medicine.

🏆 Accolades and Recognition

Dr. Mandeville’s credentials reflect longstanding recognition in the field of pediatrics. She is certified by the American Board of Pediatrics in both General Pediatrics and Pediatric Emergency Medicine—a rare and prestigious combination. Her sustained licensure in California and prior credentials in Nevada highlight her clinical credibility, while her affiliation with institutions such as UCSD and Rady Children’s Hospital place her in nationally ranked centers of pediatric care. The progression of her academic titles further underscores institutional trust in her leadership, mentorship, and research capabilities.

🌍 Impact and Influence

Throughout her career, Dr. Mandeville has consistently served at the intersection of medicine, mentorship, and systemic impact. At Rady Children’s Hospital—a major referral center in Southern California—she has influenced both the quality of emergency pediatric care and the professional development of young physicians. Her expertise and clinical judgment are undoubtedly shaping the training experiences of future pediatricians, residents, and fellows. Moreover, her presence in a teaching hospital and research-driven university ensures that her influence extends beyond clinical settings into broader academic and public health circles.

🔗 Legacy and Future Contributions

Dr. Mandeville is well-positioned to leave a lasting legacy in pediatric emergency care and clinical education. With her strong academic background, research training, and high-level clinical experience, she represents the next generation of clinician-researchers dedicated to evidence-based improvements in pediatric health. Her ongoing work at UCSD is likely to contribute to innovations in emergency care delivery, interdisciplinary teaching, and policy development in children’s health services. As medical systems increasingly prioritize translational research and quality improvement, her dual role as educator and researcher will only grow more pivotal.

🧪 Commitment to Research-Driven Medicine

What sets Dr. Mandeville apart is her integration of research training into her clinical identity. The MSCR program she completed reflects a structured and methodical approach to data analysis, study design, and outcomes research—skills that are vital in transforming bedside observations into peer-reviewed evidence. While not all research is visible in public citations, her long-term affiliation with academic medical centers and role in an evidence-based specialty suggests a strong alignment with research objectives. Her career embodies the principle that the best medical care is informed by rigorous scientific investigation, continuous learning, and collaborative innovation.

Publication

  • Title: Effects of Timing to Diagnosis and Appendectomy in Pediatric Appendicitis
    Author(s): Mandeville K, Monuteaux M, Pottker T, Bulloch B
    Year: 2015

 

  • Title: The Frequency of Postreduction Interventions After Successful Enema Reduction of Intussusception
    Author(s): Lessenich EM, Kimia AA, Mandeville K, Li J, Landschaft A, Tsai A, Bachur R
    Year: 2015

 

  • Title: Intussusception: Clinical Presentations and Imaging Characteristics
    Author(s): Mandeville K, Chien M, Willyerd FA, Mandell G, Hostetler MA, Bulloch B
    Year: 2012

 

  • Title: Management of the Child After Enema-Reduced Intussusception: Hospital or Home?
    Author(s): Chien M, Willyerd FA, Mandeville K, Hostetler MA, Bulloch B
    Year: 2012

 

  • Title: Using Appendicitis Scores in the Pediatric ED
    Author(s): Mandeville K, Pottker T, Bulloch B, Liu J
    Year: 2010

 

  • Title: Brain Oxygen Utilization Is Unchanged by Hypoglycemia in Normal Humans: Lactate, Alanine, and Leucine Uptake Are Not Sufficient to Offset Energy Deficit
    Author(s): Lubow JM, Piñón IG, Avogaro A, Cobelli C, Treeson DM, Mandeville KA, Toffolo G, Boyle PJ
    Year: 2005

 

  • Title: Presentation, Evaluation, and Outcomes of Infants Under Three Months With Skull Fractures
    Author(s): Mandeville K
    Year: Not specified (date not provided in source)

 

🏁 Conclusion

Dr. Katherine Mandeville exemplifies the role of a clinician-researcher in modern medicine. Her robust educational background, commitment to pediatric emergency care, and pursuit of research-driven solutions have positioned her as a valuable leader in her field. Her influence spans clinical innovation, academic mentorship, and systemic healthcare improvements, making her a key contributor to both pediatric patient outcomes and medical education. As she continues her work at UCSD and Rady Children’s Hospital, her legacy is poised to grow through impactful research, mentorship, and advocacy for best practices in pediatric emergency medicine.

Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Posted on by Neuroscientists

Assist. Prof. Dr. Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Assist. Prof. Dr.  Mona Fikry, Faculty of Pharmacy-Cairo University, Egypt.

Dr. Mona Fikry Said, Assistant Professor of Pharmaceutical Chemistry at Cairo University, stands out as a dedicated educator, researcher, and mentor in the field of medicinal chemistry. Her academic journey reflects a blend of deep scientific knowledge and practical teaching expertise. She has supervised numerous postgraduate theses and published extensively in prestigious journals. Her research, particularly in the synthesis and pharmacological evaluation of novel compounds for neurodegenerative diseases, highlights her commitment to addressing real-world health challenges. Beyond her publications, Dr. Said’s influence extends through academic collaboration, curriculum development, and mentorship.

Profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Mona Fikry Said began her academic journey with a strong foundation in pharmaceutical sciences, eventually channeling her passion for medicinal chemistry into advanced academic and research endeavors. Her early commitment to learning laid the groundwork for a career dedicated to both academic excellence and scientific innovation. This formative stage was marked by rigorous study and a growing interest in drug design and discovery, which shaped her professional focus.

🧪 Professional Endeavors

Currently serving as an Assistant Professor of Pharmaceutical Chemistry at the Faculty of Pharmacy, Cairo University, Dr. Said has become a respected educator and mentor in her field. She has been actively involved in teaching a wide array of pharmaceutical chemistry courses and guiding numerous master’s and doctoral students through their theses. Her role extends beyond instruction, as she also participates in academic advising and serves as an external examiner for other institutions.

🔬 Contributions and Research Focus

Dr. Said’s research is deeply rooted in pharmaceutical chemistry, with a particular focus on the development of novel bioactive compounds. Her most recent completed project, “Probing new 3-hydrazinyl indole phenacetamide derivatives as multitarget anti-Alzheimer: Synthesis, in vivo, in vitro, and in silico studies,” exemplifies her multidisciplinary approach to drug discovery. She integrates synthesis, pharmacological testing, and computational modeling to explore new therapeutic avenues, especially for neurodegenerative diseases.

🏅 Accolades and Recognition

While not always publicly documented, Dr. Said’s scientific contributions are widely acknowledged through her publications in high-impact journals such as European Journal of Medicinal Chemistry, Molecular Diversity, Bioorganic Chemistry, and Future Medicinal Chemistry. Her expertise is recognized by her academic peers, and her involvement in national academic programs highlights her standing in the pharmaceutical education community.

🌐 Impact and Influence

Through her publications in SCI and Scopus-indexed journals, Dr. Said has significantly contributed to the body of knowledge in pharmaceutical chemistry. Her work bridges theoretical research and practical applications, influencing both the academic landscape and the early stages of pharmaceutical development. By mentoring postgraduate students and collaborating across institutions, she has helped cultivate a new generation of researchers in Egypt and beyond.

📘 Legacy and Future Contributions

Dr. Said’s lasting impact lies not only in her research but also in her educational leadership. With each class she teaches and each thesis she supervises, she sows the seeds for future advancements in medicinal chemistry. Her continued involvement in clinical academic programs and university examinations ensures that her influence will resonate across institutions for years to come. Looking forward, her research aims to expand into more diverse therapeutic targets, further strengthening Cairo University’s role in pharmaceutical innovation.

🧬 Research Vision in Pharmaceutical Chemistry

With an enduring commitment to discovery, Dr. Mona Fikry Said envisions a research future driven by interdisciplinary collaboration and the integration of cutting-edge techniques. Her dedication to the design and synthesis of multitarget agents reflects a broader mission to combat complex diseases like Alzheimer’s. In doing so, she positions herself at the forefront of modern pharmaceutical chemistry, where innovation and impact go hand in hand.

Publication

  • Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents
    FA Ragab, NMA Gawad, HH Georgey, MF Said
    2013

 

  • Design and synthesis of ibuprofen-quinoline conjugates as potential anti-inflammatory and analgesic drug candidates
    AM Ghanim, AS Girgis, BM Kariuki, N Samir, MF Said, A Abdelnaser, …
    2022

 

  • Pyrazolone derivatives: Synthesis, anti-inflammatory, analgesic, quantitative structure–activity relationship and in vitro studies
    FAF Ragab, NM Abdel-Gawad, HH Georgey, MF Said
    2013

 

  • Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII
    RF George, MF Said, S Bua, CT Supuran
    2020

 

  • Synthesis, molecular modelling and QSAR study of new N-phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors
    MF Said, RF George, A Petreni, CT Supuran, NM Mohamed
    2022

 

  • Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors
    HH Hassanein, HH Georgey, MA Fouad, AM El Kerdawy, MF Said
    2017

 

  • New NSAID conjugates as potent and selective COX-2 inhibitors: Synthesis, molecular modeling and biological investigation
    RM Bokhtia, SS Panda, AS Girgis, N Samir, MF Said, A Abdelnaser, …
    2023

 

  • Development of Isatin‐Based Schiff Bases Targeting VEGFR‐2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies
    IA Seliem, SS Panda, AS Girgis, QL Tran, MF Said, MS Bekheit, …
    2022

 

  • Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential
    MF Said, HH Georgey, ER Mohammed
    2021

 

  • Novel Curcumin Mimics: Design, Synthesis, Biological Properties and Computational Studies of Piperidone‐Piperazine Conjugates
    MA Youssef, SS Panda, DR Aboshouk, MF Said, A El Taweel, M GabAllah, …
    2022

 

✅ Conclusion

Through her unwavering dedication to pharmaceutical chemistry, Dr. Said has carved out a meaningful role in academia and research. Her work not only advances scientific understanding but also nurtures future innovators in the field. With a strong foundation in both teaching and research, and a vision for multidisciplinary innovation, she is poised to continue making impactful contributions to drug discovery and pharmaceutical education in the years to come.

BaomanLi| Neuroanatomy | Best Researcher Award

Posted on by Neuroscientists

Prof. BaomanLi| Neuroanatomy| Best Researcher Award

Prof . Baoman Li, China Medical University, China.

Dr. Baoman Li is a distinguished neuroscientist and forensic toxicologist whose academic and professional journey spans advanced pharmacological research and impactful discoveries in brain science. With a Ph.D. from China Medical University and postdoctoral training in the U.S., he has built a career rooted in scientific excellence and innovation. His pioneering research—ranging from CSF transport mechanisms to neuronal excitability and circadian-based psychiatric models—has been published in leading journals. As a professor and department director, he also contributes through scholarly leadership, editorial work, and mentorship, strengthening the foundation of neuroglial and toxicological research

Profile

 

Early Academic Pursuits

Dr. Baoman Li’s academic journey began with a strong foundation in medical pharmacology, culminating in a Ph.D. from China Medical University. His early academic years were marked by a keen interest in the complex interactions between drugs and neural function, particularly within the central nervous system. Motivated by a curiosity about how neurochemical pathways influence behavior and mental health, Dr. Li pursued rigorous scientific training and research, laying the groundwork for a future at the forefront of forensic toxicology and neuropharmacology.

Professional Endeavors

Following his doctoral studies, Dr. Li expanded his academic horizons as a postdoctoral researcher at the University of Rochester Medical Center in the United States from 2013 to 2014. There, he collaborated on cross-disciplinary studies, refining his expertise in neurobiology and toxicological mechanisms. Returning to China, he assumed the role of Professor and Department Director of the Forensic Analytical Toxicology Department at China Medical University. In this position, he has led numerous high-impact research initiatives, while mentoring emerging scientists and guiding departmental development.

🧠 Contributions and Research Focus

Dr. Li’s research has contributed significantly to our understanding of the brain’s physiological and pathological processes. His recent studies have been particularly groundbreaking. He identified a previously unknown ependymal cell-mediated pathway responsible for transporting cerebrospinal fluid (CSF) from the central nervous system to peripheral organs, published in PNAS in 2024. Another major discovery, published in Cell Metabolism in 2025, revealed the role of the norepinephrine–free fatty acid–Na⁺/K⁺-ATPase axis in regulating neuronal hyperexcitability and behavioral arousal. Furthermore, his 2023 work in Molecular Psychiatry introduced a novel circadian disruption-induced manic mouse model, offering new tools for bipolar disorder research.

📚 Scholarly Contributions and Thought Leadership

Beyond laboratory discoveries, Dr. Li has demonstrated scholarly leadership through his editorial work on three comprehensive books focusing on neuroglial functions and dysfunctions. These editorial endeavors reflect his deep engagement with the academic community and his commitment to synthesizing and disseminating cutting-edge knowledge. His work bridges pharmacology, neuroscience, and psychiatry, reinforcing his reputation as a thought leader in the multidisciplinary domain of brain science and mental health.

🏅 Accolades and Recognition

Dr. Li’s scientific rigor and innovative research have earned him national and international recognition. His publications in high-impact journals have attracted attention from global neuroscientific communities, affirming the relevance and importance of his findings. As a respected academic, he frequently contributes to peer-reviewed journals and serves as a reviewer and collaborator across multiple institutions, further highlighting his expertise and integrity as a scientist.

🌍 Impact and Influence

Through his research, Dr. Li has had a significant impact on the fields of forensic toxicology, neuropharmacology, and psychiatric disorder modeling. His identification of critical neural pathways and behavioral mechanisms has implications for both clinical practice and basic science. His collaborative work continues to influence ongoing studies in neuroscience and mental health treatment strategies, and his mentorship of students ensures that his influence extends to future generations of researchers.

🔬 Legacy and Future Contributions

As Dr. Baoman Li continues his work, he remains committed to pushing the boundaries of forensic neuroscience and neuropharmacology. With a legacy rooted in innovation, academic excellence, and cross-disciplinary exploration, his future contributions are expected to further transform our understanding of brain function and disease. By integrating analytical toxicology with behavioral neuroscience, Dr. Li aims to develop novel diagnostic and therapeutic approaches that could benefit public health on a global scale.

🧾 Conclusion

Through decades of dedication, Dr. Baoman Li has emerged as a transformative figure in the intersecting fields of neuropharmacology, forensic toxicology, and psychiatric neuroscience. His work not only enhances scientific understanding but also opens new avenues for diagnosis and treatment of complex neurological and psychological disorders. As he continues to lead cutting-edge research and mentor the next generation, his influence will persist—shaping the future of brain health and forensic science across global academic and clinical landscapes.

Abdullah Alghamdi | Emerging Areas in Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Mr. Abdullah Alghamdi | Emerging Areas in Neuroscience | Best Researcher Award

Mr. Abdullah Alghamdi, University of Birmingham (UK) and Taibah University (Saudi Arabia),  United Kingdom.

Eng. Abdullah A. Zohaid (SMIEEE, SMIET) is an accomplished electrical engineer and academic with a specialization in Smart Power Systems, focusing on electric vehicles, AI-integrated transportation systems, and sustainable smart city infrastructure. With a solid educational foundation—earning distinctions at every academic level—he has seamlessly merged academic excellence with real-world engineering experience. From his early career at Saudi Aramco to his dual lecturing roles at Taibah University and the University of Birmingham, Abdullah has built a reputation as a forward-thinking researcher, educator, and strategist. His work bridges technical innovation with societal needs, aiming to optimize power grids and energy systems for a sustainable future.

Profile

Google Scholar

🎓 Early Academic Pursuits

From the historic city of Medina, Saudi Arabia, Eng. Abdullah A. Zohaid embarked on his academic journey in Electrical Engineering at Taibah University, where his talent and determination earned him distinction in his final project. His academic passion soon carried him to the United Kingdom, where he pursued an MSc in Electrical Power Systems at the University of Birmingham, graduating with First-Class Honors and distinction. Abdullah’s unwavering commitment to academic excellence continued as he embarked on a Ph.D. in Smart Power Systems at the same institution. Excelling in all areas, he has distinguished himself through both research prowess and scholastic achievement.

⚡ Professional Endeavors

Eng. Alghamdi has established himself as a dynamic professional straddling the worlds of academia and industry. His journey began with Saudi Aramco’s Dodsal Company, contributing to the vital 56″ Gas Pipeline project as an assistant electrical engineer. He transitioned into academia with his role as a Lecturer at Taibah University in Yanbu and later joined the University of Birmingham as a faculty member. Balancing dual academic roles in Saudi Arabia and the UK, Abdullah has developed a unique global perspective, blending practical engineering insight with cutting-edge educational delivery. His presence as an educator underscores his belief in empowering future engineers with real-world readiness.

🔬 Contributions and Research Focus

A scholar deeply embedded in the future of sustainable power, Eng. Alghamdi’s research focuses on Smart Power Systems, electric vehicles, smart charging infrastructures, and the integration of AI in intelligent transportation systems. Through his ongoing Ph.D. research, he explores how emerging technologies can enhance smart grid resilience and contribute to the development of smart cities. He utilizes advanced simulation and optimization tools such as MATLAB/SIMULINK, Python, and Gurobi, combined with machine learning techniques (ANN/CNN), to propose innovative solutions that address pressing energy challenges. His passion for sustainability is evident in his contributions to the global energy discourse, especially in urban mobility and decarbonization.

🏆 Accolades and Recognition

Eng. Zohaid’s career is adorned with recognition and academic milestones. His consistent distinction in every academic phase, including honors during both his MSc and Ph.D. studies, reflects a sustained trajectory of excellence. As a senior member of prestigious engineering bodies like IEEE and IET, and a certified Professional Engineer by the Saudi Council of Engineers, his credentials are a testament to his standing in the professional community. Furthermore, his publications in Q1 journals and contributions to leading international conferences validate the depth of his research and the quality of his scholarly communication.

🌍 Impact and Influence

With affiliations across IEEE working groups and university research circles, Eng. Alghamdi’s influence spans global academic and professional spheres. As a presenter and contributor at numerous high-level conferences — from the IEEE Power & Energy Society to Net Zero Futures and Saudi Innovation events — he has played a key role in shaping conversations on smart energy. His multidisciplinary expertise allows him to drive collaborations across AI, optimization, and power systems, impacting both policy and practice. His ability to simplify complex engineering concepts and communicate them effectively has enabled him to become a trusted voice among peers and students alike.

💡 Innovation and Strategic Vision

Abdullah’s strength lies in visionary thinking and strategic problem-solving. He doesn’t merely research problems—he crafts systems and strategies that reflect future-forward thinking. His approach to sustainable urban infrastructure blends technological acumen with strategic planning, leadership, and innovation. As an educator and researcher, he fosters environments that promote critical thinking and team-based innovation, cultivating the next generation of engineers equipped to face tomorrow’s challenges. His work on smart charging and intelligent transportation embodies the essence of transformative impact through design thinking and systems innovation.

🚀 Legacy and Future Contributions

Looking ahead, Eng. Abdullah A. Zohaid is poised to leave a lasting legacy in the realm of smart power systems and urban sustainability. His dual role as a lecturer and researcher gives him a powerful platform to shape both academic knowledge and real-world applications. With his continued focus on electrification, smart mobility, and AI-driven infrastructure, he is on track to influence policy, inspire innovation, and expand the boundaries of what is possible in modern power systems. His legacy will be defined not only by the technologies he helps build but also by the students and professionals he inspires along the way.

Publication

  • Innovative Prepositioning and Dispatching Schemes of Electric Vehicles for Smart Distribution Network Resiliency and Restoration
    AAM Alghamdi, D. Jayaweera, 2022

 

  • Resilience of Modern Power Distribution Networks with Active Coordination of EVs and Smart Restoration
    AAM Alghamdi, D. Jayaweera, 2023

 

  • Modelling Frameworks Applied in Smart Distribution Network Resiliency and Restoration
    AAM Alghamdi, D. Jayaweera, 2022

 

  • Resilience-Oriented Restoration in Modern Power Distribution Networks with Smart Electric Vehicles Coordination Framework
    A. Alghamdi, D. Jayaweera, 2023

 

  • Risk and Resilience Based Residential Electric Vehicle Integration Framework for Restoration of Modern Power Distribution Networks
    A. Alghamdi, D. Jayaweera, 2025

 

  • Electric Boats and Electric Vehicles Data-Driven Approach for Enhanced Resilience in Power Distribution Networks
    AAM Alghamdi, D. Jayaweera, 2025

 

✅ Conclusion

Eng. Alghamdi stands at the forefront of energy transformation, using research, innovation, and teaching as tools to drive meaningful change. His contributions reflect a blend of technical mastery and visionary leadership, enabling progress in smart mobility, clean energy, and intelligent infrastructure. With a growing portfolio of Q1 publications, prestigious memberships, and impactful conference roles, he continues to influence the field of electrical engineering on a global scale. As he advances in his career, his legacy will be marked by both technological advancements and the future minds he mentors—solidifying his role as a transformative figure in the evolution of smart power systems.